Inhibitor incidence with recombinant vs. plasma-derived FVIII in previously untreated patients with severe hemophilia A: homogeneous results from four published observational studies.
Calvez
T
T
Laurian
Y
Y
Goudemand
J
J
D005169:Factor VIII / Q000235:genetics / Q000276:immunology* / Q000302:isolation & purification; D006467:Hemophilia A / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D015994:Incidence; D007518:Isoantibodies / Q000096:biosynthesis*; D008297:Male; D015337:Multicenter Studies as Topic; D016017:Odds Ratio; D011994:Recombinant Proteins / Q000276:immunology; D012306:Risk
D007518:Isoantibodies; D011994:Recombinant Proteins; D005169:Factor VIII